News & Events
PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment demonstrates the company’s focus on developing the US market and its commercial profile within the healthcare and precision medicine fields. Simon brings with...
68 risk-associated genes identified from analysis of hospitalized COVID-19 patients suggesting opportunities for genomic biomarkers and new treatment options
PrecisionLife's unique AI platform has found 68 genes associated with risk of developing severe COVID-19 after analysis of the genomes of 929 patients from the UK Biobank who had a severe response to SARS-CoV-2. Prior to an effective and widely available vaccine,...
Shared sepsis / severe COVID-19 genetic risk factors with 59 potential drug re-purposing candidates identified in fight against COVID-19
Using PrecisionLife's proprietary AI enabled precision medicine platform we have identified 59 re-purposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from...
Tackling Coronavirus with Digital Technologies – Virtual Conference and Networking Event, Wednesday 8th April, 2020, from 2pm
PrecisionLife CEO & Founder Dr Steve Gardner will be taking part in an expert panel discussion at a Virtual Conference and Networking Event looking at ‘Digital Medicine Solutions for COVID-19’ on Wednesday April 8th at 2pm. Organised by the International Society...
PrecisionLife has confirmed it is extending its relationships with some of the largest COVID-19 collaborative research projects and is now offering free use of its unique analytics platform and support from its data and biomedical science teams to the on-going...
Sept 7th-9th 2020 - Taiwan AI/DTA International Startup Challenge event
PrecisionLife CEO Dr Steve Gardner will giving the keynote speech and taking his place on the judging panel at this unique and collaborative event that aims to identify, nurture, accelerate and support international, technology-driven startups both in Taiwan and abroad.
Sept 8th-10th 2020 - MedInvest AI, Big Data and Digital Health Conference
Taking place at 11am EST/4pm BST on day two of the event , PrecisionLife CEO Dr Steve Gardner will be discussing our unique technology and its ability to generate unique insights into the drivers of complex disease.
Sept 17th-18th 2020 - 4D meets AI conference - Advancing Drugs, Devices, Diagnostics, and Digital Health
PrecisionLife CEO Dr Steve Gardner will be moderating the AI and Omics Technologies panel session at this partnering event that connects investors and strategic partners and matches them to companies developing and commercializing AI technology.